Login to Your Account



Comparators matter for cardiovascular outcomes

By Brian Orelli
Staff Writer

Tuesday, June 13, 2017

SAN DIEGO – A pair of clinical trial presentations at the ADA 77th Scientific Sessions on Monday, both with simultaneous publications in The New England Journal of Medicine, established the cardiovascular risk of two already-approved diabetes drugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription